Partial Mediation of Glucocorticoid Antiproliferate Effects by Lipocortins

Journal of Immunology

Volumn 157, Issue 12, 1996, Pages 5231-5239

  Almawi, Wassim Y ^a   Saouda, Myrna S ^a   Stevens, Anthony C ^b   Lipman, Mark L ^b   Barth, Claudia M ^b   Strom, Terry B ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,8,11,14 ICOSATETRAYNOIC ACID; ANNEXIN; ARACHIDONIC ACID; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; NORDIHYDROGUAIARETIC ACID; PREDNISOLONE;

ARTICLE; CYTOLOGY; DRUG EFFECT; HUMAN; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY;

5,8,11,14-EICOSATETRAYNOIC ACID; ANNEXINS; ARACHIDONIC ACID; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; NORDIHYDROGUAIARETIC ACID; PREDNISOLONE;

EID: 0030589293     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Nagai, H., T. Takizawa, N. Inagaki, T. Sakamoto, T. Shimazawa, and A. Koda. 1989. Anti-allergic action of glucocorticoids. II. Effect of glucocorticoids on cell-mediated (type IV) allergic reactions. Arerugi 38:493.
2. Cupps, T. R., and A. Fauci. 1982. Glucocorticoid-mediated immunoregulation in man. Immunol. Rev. 65:133.
3. Daeron, M., A. R. Sterk, F. Hirata, and T. Ishizaka. 1982. Biochemical analysis of glucocorticoid-induced inhibition of IgE-mediated histamine release from mouse mast cells. J. Immunol. 129:1212.
4. Dennis, G., C. H. June, J. Mizuguchi, J. Ohara, K. Witherspoon, F. D. Finkelman, V. McMillan, and J. J. Mond. 1987. Glucocorticoids suppress calcium mobilization and phospholipid hydrolysis in anti-Ig antibody-stimulated B cells. J. Immunol. 139:2516.
5. Johnston, D., E. R. Matthews, and G. Melnykovych. 1980. Glucocorticoid effects on lipid metabolism in HeLa cells: inhibition of cholesterol synthesis and increased sphingomyelin synthesis. Endocrinology 107:1482.
6. Ramachandran, C. K., and G. Melnykovych. 1983. Transient changes in phospholipid methylation induced by dexamethasone on lymphoid cells. Cancer Res. 43:5725.
7. Almawi, W. Y., M. L. Lipman, A. C. Stevens, B. Zanker, E. Hadro, and T. B. Strom. 1991. Abrogation of glucocorticosteroid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-γ. J. Immunol. 146:3523.
8. Gessani, S., S. McCandless, and S. Baglioni. 1988. The glucocorticoid dexamethasone inhibits synthesis of interferon by decreasing the level of its mRNA. J. Biol. Chem. 263:7454.
9. Knudsen, P. J., C. A. Dinarello, and T. B. Strom. 1987. Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J. Immunol. 139:4129.
10. Hirata, F., M. L. Stracke, and E. Schiffmann. 1987. Regulation of prostaglandin formation by glucocorticoids and their second messenger, lipocortins. J. Steroid Biochem. 27:1053.
11. Wallner, B. P., R. J. Mattaliano, C. Hession, R. L. Cate, R. Tizard, L. K. Sinclair, C. Foeller, E. P. Chow, J. L. Browning, K. L. Ramachandran, and R. B. Pepinsky. 1986. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature 320:77.
12. Flower, R. J., and G. J. Blackwell. 1979. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 278:456.
13. Peers, S. H., and R. J. Flower. 1990. The role of lipocortin in corticosteroid actions. Am. Rev. Respir. Dis. 141:S18.
14. Wahl, L. M., and L. L. Lampel. 1987. Regulation of human peripheral blood monocyte collagenase by prostaglandins and anti-inflammatory drugs. Cell. Immunol. 105:411.
15. Webb, D. S., and J. A. Roth. 1987. Relationship of glucocorticoid suppression of arachidonic acid metabolism to alteration of neutrophil function. J. Leukocyte Biol. 41:156.
16. Russo-Marie, F., and D. Duval. 1982. Dexamethasone-induced inhibition of prostaglandin production does not result from a direct action on phospholipase activities but is mediated through a steroid-inducible factor. Biochim. Biophys. Acta 712:177.
17. Grove, R. I., W. D. Willis, and R. M. Pratt. 1985. Inhibition of arachidonic acid metabolism is not involved in dexamethasone-induced growth inhibition of embryonic palatal development. Prostaglandins Leuk. Med. 17:85.
18. Hullin, F., P. Raynal, J. M. Ragab-Thomas, J. Fauvel, and H. Chap. 1989. Effect of dexamethasone on prostaglandin synthesis and on lipocortin status in human endothelial cells: inhibition of prostaglandin 12 synthesis occurring without alteration of arachidonic acid liberation and of lipocortin synthesis. J. Biol. Chem. 264:3506.
19. Almawi, W. Y., E. T. Hadro, and T. B. Strom. 1991. Glucocorticoid-mediated immunosuppressive effects do not involve altering second messenger function. Transplantation 52:133.
20. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T. Nature 227:680.
21. Blumberg, D. D. 1987. Creating a ribonuclease-free environment. Methods Enzymol. 152:572.
22. MacDonald, R. J., G. H. Swift, A. E. Przybyla, and J. M. Chirgwin. 1987. Isolation of RNA using guanidium salts. Methods Enzymol. 152:219.
23. Holmdahl, R., and L. Jansson. 1988. Estrogen-induced suppression of collagen arthritis. III. Adult thymectomy does not affect the course of arthritis or the estrogen-mediated suppression of T cell immunity. Brain Behav. Immun. 2:123.
24. Seaman, W. E., T. C. Merigan, and N. Talal. 1979. Natural killing in estrogen-treated mice respond poorly to poly (I. C.) despite normal stimulation of circulating interferon. J. Immunol. 123:2903.
25. de Groen, P. C. 1988. Cyclosporine, low-density lipoproteins, and cholesterol. Mayo Clin. Proc. 63:1012.
26. Ablin, R. J., R. A. Ghatti, and P. Guinan. 1978. Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate. Cancer Res. 30:3702.
27. Siiteri, P. K., F. Febres, L. E. Clemens, R. J. Chang, B. Gondos, and D. P. Stites. 1977. Progesterone and maintenance of pregnancy: is progesterone nature's immunosuppressant? Ann. NY Acad. Sci. 286:384.
28. Clemens, L. E., P. K. Siiteri, and D. P. Stites. 1979. Mechanism of immunosuppression of progesterone on maternal lymphocyte activation during pregnancy. J. Immunol. 122:1978.
29. Aschkenasy, A. 1976. The effects of late thymectomy on the immunosuppressive action of cortisone and testosterone in rats immunized to sheep red blood cells. Acta Haematol. 56:212.
30. Wyle, F. A., and J. Kent. 1977. Immunosuppression by sex steroid hormones: the effect upon PHA- and PPD-stimulated lymphocytes. Clin. Exp. Immunol. 27:407.
31. Pavia, C., P. K. Siiteri, J. D. Perlman, and D. P. Stites. 1979. Suppression of murine allogeneic cell interactions by sex hormones. J. Reprod. Immunol. 1:33.
32. Bienkowski, M. J., M. A. Petro, and L. J. Robinson, 1989. Inhibition of thromboxane A synthesis in U937 cells by glucocorticoids: lack of evidence for lipocortin 1 as the second messenger. J. Biol. Chem. 264:6536.
33. van Voorhis, B. J., O. J. Anderson, and J. A. Hill. 1989. The effects of RU 486 on immune function and steroid-induced immunosuppression in vitro. J. Clin. Endocrinol. Metab. 69:1195.
34. Solito, E., G. Raugei, M. Melli, and L. Parente. 1991. Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U-937 cells. FEBS Lett. 291:238.
35. Wong, W. T., S. C. Frost, and H. S. Nick. 1991. Protein-synthesizing-dependent induction of annexin I by glucocorticoids. Biochem. J. 275:313.
36. Violette, S. M., I. King, J. L., Browning, R. B. Pepinsky, B. P. Wallner, and A. Sartorelli. 1990. Role of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma. J. Cell. Physiol. 142:70.
37. Croxtall, J. D., and R. J. Flower. 1992. Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 adenocarcinoma cell line. Proc. Natl. Acad. Sci. USA 89:3571.
38. Flower, R. J. 1988. Lipocortin and the mechanism of action of the glucocorticoids. Br. J. Pharmacol. 94:987.
39. Smith, S., T. Tetley, A. Guz, and R. Flower. 1990. Detection of lipocortin 1 in human lung lavage fluid: lipocortin degradation as a possible proteolytic mechanism in the control of inflammatory mediators and inflammation. Environ. Health Perspect. 85:135.
40. Ambrose, M. P., C. L. Bahns, and G. W. Hunninghake. 1992. Lipocortin I production by human alveolar macrophages. Am. J. Respir. Cell. Mol. Biol. 6:17.
41. Errasfa, M., and F. Russo-Marie. 1989. A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice. Br. J. Pharmacol. 97:1051.
42. Kozubik, A., J. Hofmanova, J. Hola, and J. Netikova. 1993. The effect of nordihydro-guaiaretic acid, an inhibitor of prostaglandin and leukotriene biosynthesis, on hematopoiesis of gamma irradiated mice. Exp. Hematol. 21:138.
43. Anderson, K. M., and J. E. Harris. 1990. 5,8,11,14-Eicosatetraynoic acid inhibits PC3 DNA synthesis and cellular proliferation, in part due to its 5′-lipoxygenase activity. Clin. Physiol. Biochem. 8:308.
44. - generation by dexamethasone is mimicked by lipocortin 1 in alveolar macrophages. J. Clin. Invest. 83:1936.
45. Perretti, M., and R. J. Flower. 1993. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipoconin 1. J. Immunol. 150:992.
46. Sartorelli, A. C., K. Ishiguro, C. King, M. Morin, and M. Reiss. 1986. Mechanisms involved in the induction of malignant cell differentiation. Adv. Enzyme Regul. 25:507.
47. De Caterina, R., R. Sicari, D. Giannessi, P. L. Paggiaro, P. Paoletti, G. Lazzerini, W. Bernini, E. Solito, and L. Parenti. 1993. Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. J. Appl. Physiol. 75:2368.
48. Newman, S. P., R. J. Flower, and J. D. Croxtall. 1994. Dexamethasone suppression of cyclooxygenase 2 expression is not mediated by lipocortin-1 in A549 cells. Biochem. Biophys. Res. Commun. 202:931.
49. Beyaert, R., P. Suffys, F. Van Roy, and W. Fiers. 1990. Inhibition by glucocorticoids of tumor necrosis factor-mediated cytotoxicity: evidence against lipocortin involvement. FEBS Lett. 262:93.
50. Johnsson, N., and K. Weber. 1990. Alkylation of cysteine 82 of p11 abolishes the complex formation with the tyrosine-protein kinase substrate p36 (annexin 2, calpactin 1, lipocortin 2). J. Biol. Chem. 265:14464.
51. Schlaepfer, D. D., and H. T. Haigler. 1988. In vitro protein kinase C phosphorylation sites of placental lipocortin. Biochemistry 27:4253.
52. Varticovski, L., S. B. Chahwala, M. Whitman, L. Cantley, D. Schindler, E. P. Chow, L. K. Sinclair, and R. B. Pepinsky. 1988. Location of sites in human lipocortin I that are phosphorylated by protein tyrosine kinases and protein kinases A and C. Biochemistry 27:3682.
53. Almawi, W. Y., K. L. Sewell, E. T. Hadro, B. Zanker, and T. B. Strom. 1990. Mode of action of the glucocorticosteroids as immunosuppressive agents. Prog. Leukocyte Biol. 10A:321.
54. Beato, M. 1989. Gene regulation by steroid hormones. Cell 56:335.
55. Hollenberg, S. M., V. Giguere, P. Segui, and R. M. Evans. 1987. Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell 49:39.
56. Vacca, A., M. P. Felli, A. R. Farina, S. Martinotti, M. Maroder, I. Screpanti, D. Meco, E. Petrangeli, L. Frati, and A. Gulino. 1992. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J. Exp. Med. 175:637.